Get the Stockscreener App
1.43
7.92%
0.105
Medicinova Inc stock is traded at $1.43, with a volume of 68,485.
It is up +7.92% in the last 24 hours and up +12.60% over the past month.
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
See More
Previous Close:
$1.325
Open:
$1.5
24h Volume:
68,485
Relative Volume:
2.84
Market Cap:
$70.14M
Revenue:
-
Net Income/Loss:
$-9.51M
P/E Ratio:
-7.5263
EPS:
-0.19
Net Cash Flow:
$-10.96M
1W Performance:
-2.05%
1M Performance:
+12.60%
6M Performance:
-27.78%
1Y Performance:
+8.33%
1-Day Range:
$1.33
$1.50
1-Week Range:
$1.305
$1.50
52-Week Range:
$1.12
$2.55
Medicinova Inc Stock (MNOV) Company Profile
Name
Medicinova Inc
Sector
Industry
Phone
858-373-1500
Address
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Compare MNOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.43 | 64.99M | 0 | -9.51M | -10.96M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-21 | Initiated | Maxim Group | Buy |
| Mar-25-19 | Resumed | B. Riley FBR | Buy |
| Mar-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Apr-18-17 | Initiated | Credit Suisse | Outperform |
| Jan-04-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-24-12 | Downgrade | MLV & Co | Buy → Hold |
| Oct-18-11 | Reiterated | MLV Capital | Buy |
| Jun-22-11 | Initiated | Global Hunter Securities | Buy |
| May-12-10 | Initiated | Wedbush | Outperform |
| Nov-12-08 | Reiterated | Ladenburg Thalmann | Buy |
| May-15-08 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jul-09-07 | Initiated | Punk, Ziegel & Co | Buy |
View All
Medicinova Inc Stock (MNOV) Latest News
Will MediciNova Inc. stock go up soonFree Fundamental Winners With Safe Entry Plan - Newser
Multi asset correlation models including MediciNova Inc.ROI Focused Setup Screener With Exit Markers - Newser
What markets is MBWM expanding into Is MediciNova Inc. stock a good long term investment optionAdvanced Screener Planner For 2025 - jammulinksnews.com
Medicinova, Inc. shares fall 4.20% after-hours after announcing a Standby Equity Purchase Agreement for up to $30 million. - AInvest
How volatile is MediciNova Inc. stock compared to the marketDaily Trading Entry Points For Every Investor - jammulinksnews.com
MediciNova Secures $30 Million Equity Purchase Agreement - TipRanks
Can momentum traders help lift MediciNova Inc.Technical Trend Forecast for Investors - Newser
MediciNova secures $30 million standby equity purchase agreement - Investing.com Australia
Will MediciNova Inc. benefit from macro trendsFree Pattern Detection for Entry Confirmation - Newser
Published on: 2025-07-31 20:38:06 - Newser
GlobeNewswire by Notified - The Manila Times
MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million - GlobeNewswire
MediciNova Lands Strategic $30M Equity Deal: What This Means for Its Biotech Pipeline - Stock Titan
3 Penny Stocks With Market Caps Larger Than $10M To Watch - simplywall.st
Is MediciNova Inc. stock entering bullish territoryHigh Return Trade Roadmap with Setup Filters - Newser
Why MediciNova Inc. stock attracts strong analyst attentionSwing Candidate List with Trade Cues - Newser
How Efficient Is MediciNova Inc. at Controlling Operating CostsCapital Growth Plan for New Investors - Newser
What makes MediciNova Inc. stock price move sharplyTechnical Chart Summary for Momentum Stocks - Newser
Pattern recognition hints at MediciNova Inc. upsideFree Sector Based Breakout Stock Forecast - Newser
How Trex Company Inc. stock performs during market volatilityTechnical Insight Guide for Safer Trades - Newser
How did MNOV's Q4 2024 revenue and expenses trend compared to previous quarters? - AInvest
How MediciNova Inc. stock performs during market volatilityChart Driven Entry Timing for Swing Trades - Newser
MediciNova Inc. Breaks Losing Streak — Is the Trend ReversingOversold Recovery Opportunity Stocks Attract Buyers - metal.it
Multi Factor Analysis Ranks MediciNova Inc. as Strong BuyReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it
What institutional investors are buying MediciNova Inc. stockMaster stock selection with insider knowledge - jammulinksnews.com
How many analysts rate MediciNova Inc. as a “Buy”Free Investment Community - jammulinksnews.com
What is the dividend policy of MediciNova Inc. stockCapitalize on momentum-driven investment opportunities - jammulinksnews.com
What are the latest earnings results for MediciNova Inc.Invest confidently with professional market insights - jammulinksnews.com
What is MediciNova Inc. company’s growth strategyFree Wealth Planning Blueprint - jammulinksnews.com
What are MediciNova Inc. company’s key revenue driversOutperformance with explosive growth - jammulinksnews.com
How does MediciNova Inc. compare to its industry peersDiscover breakthrough trading strategies - jammulinksnews.com
How Resilient Is MediciNova Inc. Stock During Economic DownturnsCapital Efficient Investment Tips - Newser
MediciNova Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Membership Group - Newser
What drives MediciNova Inc. stock priceLightning-fast growth - PrintWeekIndia
Is MediciNova Inc. a good long term investmentRapid return acceleration - PrintWeekIndia
What analysts say about MediciNova Inc. stock outlookAccelerated profit realization - jammulinksnews.com
Medicinova Inc Stock (MNOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):